Logo

NuGen, Genome Institute of Singapore Collaborate on Amplification System

Oct 15, 2002

NEW YORK, Oct. 15-California's NuGen Technologies will work with researchers at the Genome Institute of Singapore to develop microarray-based amplification and gene expression analysis technologies, the company said today.

 

The partners will develop NuGen's Single Primer Isothermal Amplification platform, which is a linear amplification technique. Researchers will adapt its gene expression application, Ribo-SPIA, to work with the Singaporean institute's custom-made oligonucleotide microarrays.

 

Financial details of the partnership were not revealed.

 

NuGen is a privately held company based in San Carlos, Calif. The company is working to develop a gene expression analysis product that can function with sample sizes of less than 20 ng of RNA.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.